miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2

Improving the long-term survival of patients with hepatocellular carcinoma (HCC) remains a challenge due to metastasis and recurrence. In this study, we demonstrate that the overexpression of miR-103 in HCC cells promotes epithelial-mesenchymal transition (EMT), and is associated with an enhanced me...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Li-Li, Yin, Xiao-Ran, Zhang, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203164/
https://www.ncbi.nlm.nih.gov/pubmed/30272278
http://dx.doi.org/10.3892/ijo.2018.4580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203164/
https://www.ncbi.nlm.nih.gov/pubmed/30272278
http://dx.doi.org/10.3892/ijo.2018.4580

Ejemplares similares